10 June 2021

PRIIPs Regulation: Further postponement for the fund industry announced

The European Commission recently announced a renewed extension of the transitional PRIIPs KID regime for the fund industry until 30 June 2022.

The renewed extension plans are caused by a lengthy coordination process among the European Supervisory Authorities (ESAs) on technical standards (RTS) for the PRIIPs Regulation which reconciled the draft RTS at the beginning of March 2021. The final RTS are not expected to be published until the fourth quarter of this year. Hence, the European Commission proposed to apply the PRIIPs requirements for the fund industry six months later. Accordingly, investment funds and distributors will not be required to prepare key investor information in the form of a PRIIPs KID or make it available to retail investors as part of an advisory service or distribution before July 1, 2022. We assume that the amendment will be implemented shortly via quick-fix procedure.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 05 August 2022

    GSK Update: Amendments to the German Act on Evidence of the Essential Working Conditions

    Read more
  • 25 July 2022

    GSK Update: VAT-exempt management of venture capital funds

    Read more
  • 18 July 2022

    GSK Update: AIFMD review: compromises begin to emerge

    Read more
Contact person

Robert Kramer

Partner*

+49 89 288174-95

robert.kramer@gsk.de

Philippe Lorenz

Local Partner*

+49 89 288174-662

philippe.lorenz@gsk.de

Katharina Herdl

Associate

+49 89 288174-31

katharina.herdl@gsk.de

Irina Stoliarova, LL.M.

Senior Associate

+352 271802-52

irina.stoliarova@gsk-lux.com

* Partner: a partner within the meaning of the German Partnership Companies Act.
   Local Partner: not a partner within the meaning of the German Partnership Companies Act.
CO2 Neutral